NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
Jimmy J. Caudell,Maura L. Gillison,Ellie Maghami,Sharon A. Spencer,David G. Pfister,Douglas Adkins,Andrew C. Birkeland,David M. Brizel,Paul M. Busse,Anthony J. Cmelak,A. Dimitrios Colevas,David W. Eisele,Thomas J. Galloway,Jessica L. Geiger,Robert I. Haddad,Wesley L. Hicks,Ying J. Hitchcock,Antonio Jimeno,Debra S. Leizman,Loren K. Mell,Bharat B. Mittal,Harlan A. Pinto,James W. Rocco,Cristina Rodríguez,Panayiotis Savvides,David L. Schwartz,Jatin P. Shah,David J. Sher,Maie A. St. John,Randal S. Weber,Gregory S. Weinstein,Frank Worden,J. Yang Bruce,Sue S. Yom,Weining Zhen,Jennifer L. Burns,Susan Darlow +36 more
431
TL;DR: The NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.
read more
Abstract: The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
MRI radiomics may predict early tumor recurrence in patients with sinonasal squamous cell carcinoma.
Chae Jung Park,Seo Hee Choi,Dai Ho Kim,Si Been Kim,Kyunghwa Han,Sung Soo Ahn,Won Hee Lee,Eun Chang Choi,Ki Chang Keum,Jinna Kim +9 more
6
Phase I dose escalation of stereotactic body radiation therapy and concurrent cisplatin for re-irradiation of unresectable, recurrent squamous cell carcinoma of the head and neck.
M. Echevarria,George Yang,Dung-Tsa Chen,Kedar Kirtane,Jeffery Russell,Julie A. Kish,Jameel Muzaffar,Kristen B. Otto,Tapan A. Padhya,Caitlin P. McMullen,Krupal B. Patel,Christine H. Chung,Jimmy J. Caudell +12 more
TL;DR: In this paper , a phase 1 clinical trial was conducted to establish a maximum tolerated dose of SBRT with concurrent cisplatin in previously irradiated locoregional SCCHN.
6
Effects of Cognitive Behavioral Therapy for Depression and Anxiety, Response Rates and Adverse Events in Patients with Locoregional Advanced Nasopharyngeal Carcinoma.
Feng Liu,Shengnan Fu,Yanzhu Chen,Ouying Yan,Fei Tong,Wanglian Peng,Ran Zou,Min-ni Wen,Ling Jiang,Hong-zhi Ma,Qian He,Lin Liu,Hui Yang,Xu-fen Huang,Yaqian Han,Hui Wang,Xiaohong Liu +16 more
TL;DR: In this paper, the effects of CBT on depression, anxiety, response rates, and adverse events in patients with locoregional advanced nasal cancer were investigated in a retrospective study.
6
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Cecilia Hes,A. Desilets,M. Tonneau,O. El Ouarzadi,M. De Figueiredo Sousa,Houda Bahig,Edith Filion,Phuc Felix Nguyen-Tân,Apostolos Christopoulos,M. Benlaïfaoui,L. Derosa,Carolina Alves Costa Silva,M. Ponce,Julie Malo,Wiam Belkad,D. Charpentier,F.M. Aubin,Zineb Hamilou,R. Jamal,Meriem Messaoudene,D. Soulières,Bertrand Routy +21 more
TL;DR: Patients who developed severe mucositis had decreased survival and enrichment in specific bacteria associated with mucosal inflammation, and these same bacteria have been linked to immune checkpoint inhibitor resistance.
6
Impact of miR-1/miR-133 Clustered miRNAs: PFN2 Facilitates Malignant Phenotypes in Head and Neck Squamous Cell Carcinoma
Shunichi Asai,Ayaka Koma,Nijiro Nohata,Takashi Kinoshita,Naoko Kikkawa,Mayuko Kato,C. Minemura,Katsuhiro Uzawa,Toyoyuki Hanazawa,Naohiko Seki +9 more
TL;DR: In silico analysis, four miRNAs directly bound the 3′untranslated region of PFN2 and controlled expression of the gene in HNSCC cells, and a total of 28 genes were identified that had putative miR-1-3p/miR-133a- 3p and microRNA binding sites and their expression levels were upregulated in H NSCC tissues.
References
•Book
AJCC Cancer Staging Manual
Mahul B. Amin,Stephen B. Edge,Frederick L. Greene,David R. Byrd,Robert K. Brookland,Mary Kay Washington,Jeffrey E. Gershenwald,Carolyn C. Compton,Kenneth R. Hess,Daniel C. Sullivan,J. Milburn Jessup,James D. Brierley,Lauri E. Gaspar,Richard L. Schilsky,Charles M. Balch,David P. Winchester,Elliot A. Asare,Martin Madera,Donna M. Gress,Laura R. Meyer +19 more
- 17 Sep 2013
TL;DR: Purposes and Principles of Cancer Staging and End-Results Reporting are explained.
20.9K
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang,Jonathan Harris,Richard H. Wheeler,Randal S. Weber,David I. Rosenthal,Phuc Felix Nguyen-Tân,William H. Westra,Christine H. Chung,Richard C.K. Jordan,Charles Lu,Harold Kim,Rita Axelrod,C Craig Silverman,Kevin P. Redmond,Maura L. Gillison +14 more
TL;DR: Tumor HPV status is a strong and independent prognostic factor for survival among patients with oropharyngeal cancer and the risk of death significantly increased with each additional pack-year of tobacco smoking.
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Anil K. Chaturvedi,Eric A. Engels,Ruth M. Pfeiffer,Brenda Y. Hernandez,Weihong Xiao,Esther Kim,Bo Jiang,Marc T. Goodman,Maria Sibug-Saber,Wendy Cozen,Lihua Liu,Charles F. Lynch,Nicolas Wentzensen,Richard C.K. Jordan,Sean F. Altekruse,William F. Anderson,Philip S. Rosenberg,Maura L. Gillison +17 more
TL;DR: In this article, the prevalence of human papillomavirus (HPV) infection in oropharyngeal cancer was determined for all 271 oropharygeal cancers (1984-2004) collected by the three population-based cancer registries in the Surveillance, Epidemiology, and End Results (SEER) Residual Tissue Repositories Program.
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
Maura L. Gillison,Wayne M. Koch,Randolph B. Capone,Michael Spafford,William H. Westra,Li Wu,Marianna Zahurak,Richard W. Daniel,Michael P. Viglione,David Eric Symer,Keerti V. Shah,David Sidransky +11 more
TL;DR: It is suggested that HPV-positive oropharyngeal cancers comprise a distinct molecular, clinical, and pathologic disease entity that is likely causally associated with HPV infection and that has a markedly improved prognosis.
3.2K
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
Jay S. Cooper,Thomas F. Pajak,Arlene A. Forastiere,John R. Jacobs,Bruce H. Campbell,Scott Saxman,Julie A. Kish,Harold Kim,Anthony J. Cmelak,Marvin Rotman,Mitchell Machtay,John F. Ensley,K.S.Clifford Chao,Christopher J. Schultz,Nancy M. Lee,Karen K. Fu +15 more
TL;DR: Among high-risk patients with resected head and neck cancer, concurrent postoperative chemotherapy and radiotherapy significantly improve the rates of local and regional control and disease-free survival, however, the combined treatment is associated with a substantial increase in adverse effects.
3.1K